Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral Mucositis Induced By Anticancer Therapies.
Al-Ansari S, Zecha JA, Barasch A, de Lange J, Rozema FR, Raber-Durlacher JE. Al-Ansari S, et al. Curr Oral Health Rep. 2015;2(4):202-211. doi: 10.1007/s40496-015-0069-4. Epub 2015 Oct 19. Curr Oral Health Rep. 2015. PMID: 26523246 Free PMC article. Review.
Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life.
Elting LS, Keefe DM, Sonis ST, Garden AS, Spijkervet FK, Barasch A, Tishler RB, Canty TP, Kudrimoti MK, Vera-Llonch M; Burden of Illness Head and Neck Writing Committee. Elting LS, et al. Cancer. 2008 Nov 15;113(10):2704-13. doi: 10.1002/cncr.23898. Cancer. 2008. PMID: 18973181 Free article.
Oral mucositis.
Raber-Durlacher JE, Elad S, Barasch A. Raber-Durlacher JE, et al. Oral Oncol. 2010 Jun;46(6):452-6. doi: 10.1016/j.oraloncology.2010.03.012. Epub 2010 Apr 18. Oral Oncol. 2010. PMID: 20403721 Review.
Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients.
Raber-Durlacher JE, von Bültzingslöwen I, Logan RM, Bowen J, Al-Azri AR, Everaus H, Gerber E, Gomez JG, Pettersson BG, Soga Y, Spijkervet FK, Tissing WJ, Epstein JB, Elad S, Lalla RV; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Raber-Durlacher JE, et al. Support Care Cancer. 2013 Jan;21(1):343-55. doi: 10.1007/s00520-012-1594-5. Epub 2012 Sep 18. Support Care Cancer. 2013. PMID: 22987094 Review.
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O, Peterson DE, Raber-Durlacher JE, Sonis ST, Elad S; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). Lalla RV, et al. Cancer. 2014 May 15;120(10):1453-61. doi: 10.1002/cncr.28592. Epub 2014 Feb 25. Cancer. 2014. PMID: 24615748 Free PMC article. Review.
Oral complications in hematopoietic stem cell recipients: the role of inflammation.
Haverman TM, Raber-Durlacher JE, Rademacher WM, Vokurka S, Epstein JB, Huisman C, Hazenberg MD, de Soet JJ, de Lange J, Rozema FR. Haverman TM, et al. Mediators Inflamm. 2014;2014:378281. doi: 10.1155/2014/378281. Epub 2014 Apr 10. Mediators Inflamm. 2014. PMID: 24817792 Free PMC article. Review.
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement.
Buglione M, Cavagnini R, Di Rosario F, Sottocornola L, Maddalo M, Vassalli L, Grisanti S, Salgarello S, Orlandi E, Paganelli C, Majorana A, Gastaldi G, Bossi P, Berruti A, Pavanato G, Nicolai P, Maroldi R, Barasch A, Russi EG, Raber-Durlacher J, Murphy B, Magrini SM. Buglione M, et al. Crit Rev Oncol Hematol. 2016 Jan;97:131-42. doi: 10.1016/j.critrevonc.2015.08.010. Epub 2015 Aug 12. Crit Rev Oncol Hematol. 2016. PMID: 26318095 Review.
98 results